Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
1(10%)
Results Posted
50%(2 trials)
Terminated
2(20%)

Phase Distribution

Ph phase_2
4
40%
Ph phase_3
2
20%
Ph phase_4
1
10%
Ph not_applicable
2
20%
Ph phase_1
1
10%

Phase Distribution

1

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
4(40.0%)
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(4)
Terminated(2)
Other(2)

Detailed Status

Completed4
unknown2
Terminated2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 24 (40.0%)
Phase 32 (20.0%)
Phase 41 (10.0%)
N/A2 (20.0%)

Trials by Status

recruiting110%
unknown220%
completed440%
not_yet_recruiting110%
terminated220%

Recent Activity

1 active trials
Showing 5 of 10
not_yet_recruitingphase_3

Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.

NCT07296146
recruitingphase_4

Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled Trial

NCT06670963
terminatedphase_2

Erythropoietin in Premature Infants to Prevent Encephalopathy

NCT02550054
unknownnot_applicable

The Effect of Micro-doses Erytropoietin on Exercise Capacity in Male and Females

NCT04965961
terminatedphase_1

Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery

NCT02189889
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07296146Phase 3

Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.

Not Yet Recruiting
NCT06670963Phase 4

Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled Trial

Recruiting
NCT02550054Phase 2

Erythropoietin in Premature Infants to Prevent Encephalopathy

Terminated
NCT04965961Not Applicable

The Effect of Micro-doses Erytropoietin on Exercise Capacity in Male and Females

Unknown
NCT02189889Phase 1

Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery

Terminated
NCT01378273Phase 3

Preterm Erythropoietin Neuroprotection Trial (PENUT Trial)

Completed
NCT03919500Phase 2

Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis

Completed
NCT00517621Phase 2

Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire

Completed
NCT00648089Phase 2

EPOMI Study: ErythroPOietin in Myocardial Infarction

Completed
NCT00818103Not Applicable

Characteristic Study on Chinese Patients With Multiple Sclerosis

Unknown

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10